Population
124 heart transplantation (HT) recipients
Design
Cohort
Follow-up
mean 6.7 months (range 1 to 24 months)
Authors
Loading...
Enhanced platelet aggregability was associated with coronary thrombi in transplant recipients; hypothesis-generating for antiplatelet strategies in cardiac allograft vasculopathy.
Enhanced platelet aggregation is associated with coronary thrombosis and graft failure in heart transplant recipients, suggesting a role in accelerated coronary artery disease.
Lorgeril et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: